This last observation is intriguing as we recently reported that IGF-1 levels are deficient before the clinical onset of T1D in at-risk subjects (91), potentially contributing to a decrease in SIRPα signaling in β-cells. Here, SIRPA is linked to type 1 diabetes mellitus.